Reference no: EM133657028
Question
What is one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating Major depressive disorder with mixed features chronic: symptoms have been present for three months with daily occurrence. (Symptoms: withdrawal, apathy, lack of vigor, sadness)
What risk assessments would you use to inform your treatment decision-making in the older adult population?
What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
What clinical practice guidelines exist for this disorder, and if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
Reflection: one FDA-approved drug, one non-FDA-approved "off-label" drug, and one nonpharmacological intervention for treating the disorder in that population (older adult).
Support your reasoning with at least three current, credible scholarly resources, one each on the FDA-approved drug, the off-label, and a nonpharmacological intervention for the disorder.